HOXA5 regulates hMLH1 expression in breast cancer cells

Neoplasia

Volumn 8, Issue 4, 2006, Pages 250-258

  Duriseti, Sai ^a   Winnard Jr , Paul T ^a   Mironchik, Yelena ^a   Vesuna, Farhad ^a   Raman, Ana ^b   Raman, Venu ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

Author keywords

Breast cancer; Homeotic gene; Mismatch repair; Promoter analyses; Yeast

Indexed keywords

HOMEOBOX PROTEIN HOXA5; HOMEODOMAIN PROTEIN; PROTEIN MLH1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; YEAST;

EID: 33646399145     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.05766     Document Type: Article

References (39)

1. Larochelle C, Tremblay M, Bernier D, Aubin J, and Jeannotte L (1999). Multiple cis-acting regulatory regions are required for restricted spatio-temporal Hoxa5 gene expression. Dev Dyn 214, 127-140.
2. Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, Marks J, and Sukumar S (2000). Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 405, 974-978.
3. Raman V, Tamori A, Vali M, Zeller K, Korz D, and Sukumar S (2000). HOXA5 regulates expression of the progesterone receptor. J Biol Chem 275, 26551-26555.
4. Li GM (2003). DNA mismatch repair and cancer. Front Biosci 8, d997-d1017.
5. Stojic L, Brun R, and Jiricny J (2004). Mismatch repair and DNA damage signalling. DNA Repair (Amsterdam) 3, 1091-1101.
6. Mitchell RJ, Farrington SM, Dunlop MG, and Campbell H (2002). Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: a HuGE review. Am J Epidemiol 156, 885-902.
7. Seitz S, Wassmuth P, Plaschke J, Schackert HK, Karsten U, Santibanez-Koref MF, Schlag PM, and Scherneck S (2003). Identification of microsatellite instability and mismatch repair gene mutations in breast cancer cell lines. Genes Chromosomes Cancer 37, 29-35.
8. Stone JG, Coleman G, Gusterson B, Marossy A, Lakhani SR, Ward A, Nash A, McKinna A, A'Hern R, Stratton MR, et al. (2001). Contribution of germline MLH1 and MSH2 mutations to lobular carcinoma in situ of the breast. Cancer Lett 167, 171-174.
9. Murata H, Khattar NH, Gu L, and Li GM (2005). Roles of mismatch repair proteins hMSH2 and hMLH1 in the development of sporadic breast cancer. Cancer Lett 223, 143-150.
10. Ito H, Fukuda Y, Murata K, and Kimura A (1983). Transformation of intact yeast cells treated with alkali cations. J Bacteriol 153, 163-168.
11. Wells J and Farnham PJ (2002). Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitation. Methods 26, 48-56.
12. Odenwald WF, Garbern J, Arnheiter H, Tournier-Lasserve E, and Lazzarini RA (1989). The Hox-1.3 homeo box protein is a sequence-specific DNA-binding phosphoprotein. Genes Dev 3, 158-172.
13. Ito E, Yanagisawa Y, Iwahashi Y, Suzuki Y, Nagasaki H, Akiyama Y, Sugano S, Yuasa Y, and Maruyama K (1999). A core promoter and a frequent single-nucleotide polymorphism of the mismatch repair gene hMLH1. Biochem Biophys Res Commun 256, 488-494.
14. Lei X, Zhu Y, Tomkinson A, and Sun L (2004). Measurement of DNA mismatch repair activity in live cells. Nucleic Acids Res 32, e100.
15. Zhong H and Vershon AK (1997). The yeast homeodomain protein MATalpha2 shows extended DNA binding specificity in complex with Mcm1. J Biol Chem 272, 8402-8409.
16. Pramila T, Miles S, GuhaThakurta D, Jemiolo D, and Breeden LL (2002). Conserved homeodomain proteins interact with MADS box protein Mcm1 to restrict ECB-dependent transcription to the M/G1 phase of the cell cycle. Genes Dev 16, 3034-3045.
17. Roth-Ben Arie Z, Altboum Z, Berdicevsky I, and Segal E (1998). Isolation of a petite mutant from a histidine auxotroph of Candida albicans and its characterization. Mycopathologia 141, 127-135.
18. Prince VE and Pickett FB (2002). Splitting pairs: the diverging fates of duplicated genes. Nat Rev Genet 3, 827-837.
19. Ruddle FH, Bartels JL, Bentley KL, Kappen C, Murtha MT, and Pendleton JW (1994). Evolution of HOX genes. Annu Rev Genet 28, 423-442.
20. Kappen C, Schughart K, and Ruddle FH (1993). Early evolutionary origin of major homeodomain sequence classes. Genomics 18, 54-70.
21. Lewis MT (2000). Homeobox genes in mammary gland development and neoplasia. Breast Cancer Res 2, 158-169.
22. Chen F and Capecchi MR (1999). Paralogous mouse Hox genes, Hoxa9, Hoxb9, and Hoxd9, function together to control development of the mammary gland in response to pregnancy. Proc Natl Acad Sci USA 96, 541-546.
23. Cillo C, Faiella A, Cantile M, and Boncinelli E (1999). Homeobox genes and cancer. Exp Cell Res 248, 1-9.
24. Waltregny D, Alami Y, Clausse N, de Leval J, and Castronovo V (2002). Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation. Prostate 50, 162-169.
25. Hamada J-I, Omatsu T, Okada F, Furuuchi K, Okubo Y, Takahashi Y, Tada M, Miyazaki YJ, Taniguchi Y, Shirato H, et al. (2001). Overexpression of homeobox gene HOXD3 induces coordinate expression of metastasis-related genes in human lung cancer cells. Int J Cancer 93, 516-525.
26. Chario A and Castronovo V (1996). Detection of HOXA1 expression in human breast cancer. Biochem Biophys Res Commun 222, 292-297.
27. Bodey B, Bodey B Jr, Siegel S, and Kaiser HE (2000). Immunocytochemical detection of the homeobox B3, B4, and C6 gene products in breast carcinomas. Anticancer Res 20, 3281-3286.
28. Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E, Ringer M, Sauter G, Monni O, Elkahloun A, et al. (2002). Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 62, 6240-6245.
29. Nigro JM, Sikorski R, Reed SI, and Vogelstein B (1992). Human p53 and CDC2Hs genes combine to inhibit the proliferation of Saccharomyces cerevisiae. Mol Cell Biol 12, 1357-1365.
30. Kaufmann E (1993). In vitro binding to the leucine tRNA gene identifies a novel yeast homeobox gene. Chromosoma 102, 174-179.
31. Alland L, David G, Shen-Li H, Potes J, Muhle R, Lee HC, Hou H Jr, Chen K, and DePinho RA (2002). Identification of mammalian Sds3 as an integral component of the Sin3/histone deacetylase corepressor complex. Mol Cell Biol 22, 2743-2750.
32. Bennett CB, Lewis LK, Karthikeyan G, Lobachev K, Jin YH, Sterling JF, Snipe JR, and Resnick MA (2001). Genes required for ionizing radiation resistance in yeast. Nat Genet 29, 426-434.
33. Wu X, Khalpey Z, and Cascalho M (2004). Cellular physiology of mismatch repair. Curr Pharm Des 10, 4121-4126.
34. Yanamadala S and Ljungman M (2003). Potential role of MLH1 in the induction of p53 and apoptosis by blocking transcription on damaged DNA templates. Mol Cancer Res 1, 747-754.
35. Johnson RA, Ince TA, and Scotto KW (2001). Transcriptional repression by p53 through direct binding to a novel DNA element. J Biol Chem 276, 27716-27720.
36. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM, and Kolodner R (1997). Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57, 808-811.
37. Deng G, Chen A, Hong J, Chae HS, and Kim YS (1999). Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res 59, 2029-2033.
38. Quaresima B, Faniello MC, Baudi F, Cuda G, Grandinetti C, Tassone P, Costanzo F, and Venuta S (2001). Transcriptional regulation of the mismatch repair gene hMLH1. Gene 275, 261-265.
39. Arita M, Zhong X, Min Z, Hemmi H, and Shimatake H (2003). Multiple sites required for expression in 5′-flanking region of the hMLH1 gene. Gene 306, 57-65.